Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The African swine fever virus (ASFV) p54 protein is a critical structural and functional component of the ASFV virion. It is encoded by the E183L gene and has a molecular weight of approximately 25 kDa. The protein is classified as a type I transmembrane protein, localizing predominantly to the external envelope of the virus and associating with endoplasmic reticulum (ER)-derived membranes during viral assembly. It is essential for recruitment and transformation of ER membranes into viral envelope precursors, facilitating intracellular transport of viral capsids. It also plays a role in virus attachment to target cells. p54 is highly immunogenic, inducing neutralizing antibodies upon infection or immunization and is considered a potential vaccine candidate.
Antibody neutralization of viral entry/assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on African Swine Fever Virus p54 Protein (p54).